Apotex Agrees to $26 Million Drug Pricing Settlement in Texas

Canadian generics manufacturer Apotex has agreed to pay the state of Texas $26 million to settle charges that the company reported inflated drug prices to the state’s Medicaid program for more than 30 years.
Source: Drug Industry Daily